SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma
- PMID: 11854908
- PMCID: PMC4695601
- DOI: 10.3748/wjg.v7.i6.816
SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma
Abstract
Aim: To explore the role of SF/HGF-Met autocrine and paracrine in metastasis of hepatocellular carcinoma (HCC).
Methods: SF/HGF and c-met transcription and protein expression in HCC were examined by RT-PCR and Western Blot in 4 HCC cell lines, including HepG2, Hep3B, SMMC7721 and MHCC-1, the last cell line had a higher potential of metastasis. sf/hgf cDNA was transfected by the method of Lipofectin into SMMC7721. SF/HGF and c-met antibody were used to stimulate and block SF/HGF-c-met signal transduction. Cell morphology, mobility, and proliferation were respectively compared by microscopic observation, wound healing assay and cell growth curve.
Results: HCC malignancy appeared to be relative to its met-SF/HGF expression. In MHCC-1, c-met expression was much stronger than that in other cell lines with lower potential of metastasis and only SF/HGF autocrine existed in MHCC-1. After sf/hgf cDNA transfection or conditioned medium of MHCC-1 stimulation, SMMC7721 changed into elongated morphology, and the abilities of proliferation (P < 0.05) and mobility increased. Such bio-activity could be blocked by c-met antibody (P < 0.05).
Conclusion: The system of SF/HGF-c-met autocrine and paracrine played an important role in development and metastasis potential of HCC. Inhibition of SF/HGF-c-met signal transduction system may reduce the growth and metastasis of HCC.
Figures



Similar articles
-
HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways.Exp Cell Res. 2001 Jul 15;267(2):258-66. doi: 10.1006/excr.2001.5240. Exp Cell Res. 2001. PMID: 11426944
-
Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.Hepatology. 1997 Dec;26(6):1458-66. doi: 10.1053/jhep.1997.v26.pm0009397985. Hepatology. 1997. PMID: 9397985
-
Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.Mol Cancer Ther. 2009 Oct;8(10):2803-10. doi: 10.1158/1535-7163.MCT-09-0125. Mol Cancer Ther. 2009. PMID: 19825800
-
The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis.EXS. 1995;74:89-121. doi: 10.1007/978-3-0348-9070-0_6. EXS. 1995. PMID: 8527903 Review.
-
[HGF/c-Met and metastasis of hepatocellular carcinoma].Zhonghua Gan Zang Bing Za Zhi. 2005 May;13(5):396-8. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15918987 Review. Chinese. No abstract available.
Cited by
-
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.Cancer Res. 2009 Apr 1;69(7):3021-31. doi: 10.1158/0008-5472.CAN-08-2881. Epub 2009 Mar 24. Cancer Res. 2009. PMID: 19318576 Free PMC article.
-
The tumor distance to the main hepatic vessels is a predictor of recurrence-free survival and overall survival in hepatocellular cancer.Langenbecks Arch Surg. 2025 Jan 9;410(1):31. doi: 10.1007/s00423-024-03565-9. Langenbecks Arch Surg. 2025. PMID: 39786609 Free PMC article.
-
Gangliosides as Signaling Regulators in Cancer.Int J Mol Sci. 2021 May 11;22(10):5076. doi: 10.3390/ijms22105076. Int J Mol Sci. 2021. PMID: 34064863 Free PMC article. Review.
-
Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis.World J Gastroenterol. 2003 Feb;9(2):267-70. doi: 10.3748/wjg.v9.i2.267. World J Gastroenterol. 2003. PMID: 12532445 Free PMC article.
-
Genetically modified animal models recapitulating molecular events altered in human hepatocarcinogenesis.Clin Transl Oncol. 2009 Apr;11(4):208-14. doi: 10.1007/s12094-009-0342-x. Clin Transl Oncol. 2009. PMID: 19380297 Review.
References
-
- Atabey N, Gao Y, Yao ZJ, Breckenridge D, Soon L, Soriano JV, Burke TR, Bottaro DP. Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. J Biol Chem. 2001;276:14308–14314. - PubMed
-
- Furge KA, Zhang YW, Vande Woude GF. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene. 2000;19:5582–5589. - PubMed
-
- Shaharabany M, Abramovitch R, Kushnir T, Tsarfaty G, Ravid-Megido M, Horev J, Ron R, Itzchak Y, Tsarfaty I. In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors. Cancer Res. 2001;61:4873–4878. - PubMed
-
- Boccaccio C, Andò M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature. 1998;391:285–288. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous